Invert GTM brain
Invert connects and analyzes bioprocess data for development and manufacturing teams in biopharma, synthetic biology and CDMOs.
category
Bioprocess data infrastructure and analyticsmarket profile
- text: Bioprocess teams work across instruments, systems and unit operations, creating manual data preparation and fragmented context.
- text: The platform serves process development through manufacturing across modalities including biologics, cell therapy and fermentation.
personas
- title: Head of process developmentpains:
- Scientists lose time exporting instrument data, aligning timestamps and normalizing units
- Experimental learnings get lost between runs and teams
- title: MSAT or manufacturing science leadpains:
- Troubleshooting across unit operations requires combining data from multiple sources
- Transferring process knowledge into manufacturing takes manual reconciliation
- title: Biopharma digital and IT leaderpains:
- Long integrations delay returns from digital twin investments
- Regulated teams require security and auditability across data systems
icp
- text: Biopharma and biologics CDMOs running process development, pilot plants or manufacturing with multiple instruments and systems.
- text: Clinical-stage cell therapy teams and large biopharma organizations with fragmented process data; company showcases examples at both ends.
- text: Synthetic biology and fermentation producers seeking to connect bioreactors and analytical systems.
message pillars
- text: Connect equipment and data across development and manufacturing.
- text: Reduce scientists' manual data management workload.
- text: Preserve experiment learnings as reusable knowledge.
- text: Enable analysis across unit operations.
objections
- objection: Integration with our instruments will take too long.response: Scope a pilot around specific instruments and data sources; the site presents a digital twin integration example, but timing should be validated for the account.
- objection: Will it satisfy regulated workflows?response: Review the applicable security documentation, audit trail and 21 CFR Part 11 controls with quality and IT.
- objection: Why replace spreadsheets or an internal data project?response: Quantify manual data preparation and the effort of maintaining integrations, then compare on a representative program.
competitors
- name: DataHowwhy: Bioprocess modeling and analytics competitor identified by CB Insights.
- name: Benchlingwhy: Life sciences data platform and alternative for scientific workflows.
- name: New Wave Biotechwhy: Biomanufacturing decision intelligence alternative.
influencers
- name: Holger Hjorth Thorupurl: https://www.linkedin.com/posts/invertinc_biotech-bioprocess-activity-7442972065504317440-B7fTwhy: Co-founder and CTO discussing AI analysis of bioprocess data.
keywords
- bioprocess data platform
- biomanufacturing analytics software
- bioreactor data integration
- process development data management
- bioprocess digital twin
- MSAT data analytics
- fermentation process analytics
voice
- Technical and specific
- Outcome-oriented
- Confident about scientific speed
signals
- text: Hiring process data scientists or MSAT staff to reconcile instrument data.
- text: Launching a digital twin or connecting bioreactors, LIMS and ELN across a new facility.
- text: Scaling cell therapy or biologics from development into manufacturing.
stack
- Bioreactors
- LIMS
- ELN
- historian systems
hiring
- Implementation Manager
- Solutions Engineer
- Senior Software Engineer
- Director of Strategic Accounts
pricing
model: contact_sales
motion
hybridchannels
- Webinars
- SEO
- Events
confidence
highFounders
- name: Martin T. Permintitle: Founderrole: Founderbio: Hi, I'm Martin. I care about bio and data stuff. I also like to run really long distances on mountain trails. Previously, I worked at Airbnb, and Hive (YC s14).
- name: Holger Thoruptitle: Founderrole: Founderbio: Prev. VP of Eng at ZeroNorth, CTO/Founder at Pelion, and a recovering consultant.